A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons

AUTOR(ES)

Zheng, Ya-Li

FONTE

Nature Publishing Group

RESUMO

The extracellular aggregation of amyloid β (Aβ) peptides and the intracellular hyperphosphorylation of tau at specific epitopes are pathological hallmarks of neurodegenerative diseases such as Alzheimer's disease (AD). Cdk5 phosphorylates tau at AD-specific phospho-epitopes when it associates with p25. p25 is a truncated activator, which is produced from the physiological Cdk5 activator p35 upon exposure to Aβ peptides. We show that neuronal infections with Cdk5 inhibitory peptide (CIP) selectively inhibit p25/Cdk5 activity and suppress the aberrant tau phosphorylation in cortical neurons. Furthermore, Aβ1−42-induced apoptosis of these cortical neurons was also reduced by coinfection with CIP. Of particular importance is our finding that CIP did not inhibit endogenous or transfected p35/Cdk5 activity, nor did it inhibit the other cyclin-dependent kinases such as Cdc2, Cdk2, Cdk4 and Cdk6. These results, therefore, provide a strategy to address, and possibly ameliorate, the pathology of neurodegenerative diseases that may be a consequence of aberrant p25 activation of Cdk5, without affecting ‘normal' Cdk5 activity.

Documentos Relacionados

• Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
• The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons.
• Cellular Senescence Requires CDK5 Repression of Rac1 Activity
• Perinatal abrogation of Cdk5 expression in brain results in neuronal migration defects
• Cdk5 Regulates the Organization of Nestin and Its Association with p35